HER 2 + Lung Cancer Treatment? https://coloradocancerblogs…
HER 2 + Lung Cancer Treatment?
Will tarloxotinib finally break the HER2 barrier in lung cancer? - Colorado Cancer Blogs
The HER2 gene is a well-known driver of breast cancer, where changes in this gene are found in about 1-in-5 cases of the disease. HER2 also contributes to about 3 percent of lung cancers, representing about 6,500 patients per year. But while drugs like trastuzumab and lapatinib have proven effective in silencing the action of HER2 in breast cancer, there are currently no approved HER2-targeted therapies for the treatment of lung cancer.